Bronchial Artery Embolization for Life-Threatening Hemoptysis in COVID-19 Patients

Area of Science:

• Pulmonology
• Infectious Diseases
• Interventional Radiology

Background:

• The global COVID-19 pandemic presents diverse clinical manifestations, including severe respiratory distress.
• Hemoptysis, or coughing up blood, is a significant symptom in some COVID-19 patients, indicating potential severity.
• Massive hemoptysis in this context is often associated with secondary infections like pulmonary aspergillosis or pre-existing bronchiectasis, exacerbated by treatments such as corticosteroid therapy.

Observation:

• This study details five cases of patients with COVID-19 experiencing massive hemoptysis.
• The underlying causes identified were primarily pulmonary aspergillosis and severe bronchiectasis.
• These patients underwent bronchial artery embolization (BAE) as a critical intervention.

Findings:

• Bronchial artery embolization was successfully performed in all five cases, effectively controlling the massive hemoptysis.
• The intervention proved to be life-saving, stabilizing patients with severe bleeding.
• The treated conditions were predominantly linked to aspergillosis and bronchiectasis in the context of COVID-19.

Implications:

• Bronchial artery embolization is a viable and effective life-saving procedure for managing massive hemoptysis in COVID-19 patients.
• This approach addresses a critical and potentially fatal complication, particularly when related to fungal infections or bronchiectasis.
• The findings support the consideration of BAE in the multidisciplinary management of severe hemoptysis during the COVID-19 pandemic.